Agilisium Strengthens Its Presence in India with the Opening of a New Office in Hyderabad

Hyderabad, 6th September 2024: Strengthening its presence in India, Agilisium a premier data innovation partner for the Life Sciences Industry, today announced the setting up of a new development centre in Hyderabad in RMZ Spire campus. Located in Cybercity, the brand-new office is in the midst of a thriving pharmaceutical hub, strengthening its ability to offer innovative solutions, including co-locating with clients in the same hub. The company has over 700 professionals in India and expects to cross the 1,000 employee mark by the end of 2024.

The newly inaugurated office will serve as a hub for delivering advanced data and analytics solutions tailored to the unique demands of the industry. From leveraging AI and ML to cloud-based solutions, Agilisium is well-positioned to support clients in navigating the industry's complexities with agility and precision. The new facility is expected to add over 100 new roles, providing advanced technology solutions spanning the entire Life Sciences value chain from discovery to clinical trials, manufacturing and commercial operations.  

Commenting on the occasion, Mr Raj Babu, Founder and CEO, Agilisium, said, “Our expansion to Hyderabad is a decisive step in our growth strategy. This new office will function as a Global Delivery Center (GDC) and a Digital Innovation Center of Excellence (DI COE) to develop innovative solutions and better serve our growing pharmaceutical client base. With this new center, Agilisium will be in 10 locations across 7 countries catering to our global clientele. With Hyderabad deemed as one of Pharma hubs of India and home to the renowned Genome Valley, we are positioning ourselves within a conducive ecosystem of leading industry players, exceptional talent, and advanced research infrastructure.”

About Agilisium

‍Agilisium is one of the premier data innovation partners for the Life Sciences Industry. The company delivers cutting-edge solutions that drive impactful change by combining our strong domain expertise with Data, Cloud, GenAI, and Advanced Analytics. Agilisium collaborates with leading pharma and biotech companies to provide data-driven insights and innovative solutions across the value chain, helping accelerate drug discovery, optimize patient care, achieve commercial success, streamline product delivery, and foster collaboration. The company’s commitment to rigorous execution and continuous innovation enables it to shape the future of the Life Sciences industry. Learn more at www.agilisium.com